Real-World Study of DLBCL With Different Genetic Subtypes

This study is collecting information on real-world treatment outcomes for people with diffuse large B-cell lymphoma (DLBCL), a common and aggressive type of blood cancer, based on its specific genetic subtype. There are 7 known genetic subtypes of DLBCL, and researchers want to understand whether certain subtypes respond differently to treatment. **You may be eligible if...** - You have been diagnosed with diffuse large B-cell lymphoma (DLBCL) confirmed by tissue testing - Your lymphoma has been classified into one of the recognized genetic subtypes (MCD, BN2, N1, ST2, A53, EZB, etc.) using advanced genetic sequencing - You have signed the informed consent form **You may NOT be eligible if...** - You refuse to use contraception during the study period (if of childbearing age) - You have severe mental illness that would interfere with participation - The study investigator determines you are not a suitable candidate Talk to your doctor to see if this trial is right for you.